Sarah Goldberg
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC (NCT04925986) | Sarah Goldberg | 2022-02-10 |
Track Sarah Goldberg automatically
Every clearance here is in the API, with alerts when new ones post.